159 filings
DEF 14A
LTRN
Lantern Pharma Inc
Definitive proxy
29 Apr 24
7:30am
144
LTRN
Lantern Pharma Inc
26 Apr 24
Notice of proposed sale of securities
9:41pm
144
LTRN
Lantern Pharma Inc
26 Apr 24
Notice of proposed sale of securities
9:40pm
144
LTRN
Lantern Pharma Inc
26 Apr 24
Notice of proposed sale of securities
9:39pm
144
LTRN
Lantern Pharma Inc
26 Apr 24
Notice of proposed sale of securities
9:38pm
144
rzo3p34 vsd6
26 Apr 24
Notice of proposed sale of securities
9:36pm
8-K
ad0jmcsv 61bw
18 Mar 24
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights
4:05pm
SC 13D/A
qzg8hps3krk4ag
1 Mar 24
Lantern Pharma / Bios Equity Partners ownership change
4:10pm
4
bwvkwle3 dhmont
29 Feb 24
Lantern Pharma / Aaron G.L. Fletcher ownership change
9:54pm
4
bb47fzen 6n0y1c
29 Feb 24
Lantern Pharma / Leslie W. Kreis ownership change
9:54pm
144
hht99llnmx6h cz7
28 Feb 24
Notice of proposed sale of securities
9:41pm
144
tlwxb78bbqxggjxw
28 Feb 24
Notice of proposed sale of securities
9:41pm
144
wa5g8ap ewk
28 Feb 24
Notice of proposed sale of securities
9:40pm
SC 13G/A
ylz6tq3
14 Feb 24
Lantern Pharma / ProPhase Labs ownership change
4:05pm
4
mv0rr24s98gfpez yyy
19 Jan 24
Lantern Pharma / Aaron G.L. Fletcher ownership change
4:31pm
4
jz4 2mggkra6tyt8xjub
19 Jan 24
Lantern Pharma / Leslie W. Kreis ownership change
4:30pm
8-K
uo2mpqd0
29 Dec 23
Departure of Directors or Certain Officers
4:05pm
SC 13D/A
wi3hf6i0hcbzq1s
1 Dec 23
Lantern Pharma / Bios Equity Partners ownership change
6:02am
4
c2qd3d
1 Dec 23
Lantern Pharma / Aaron G.L. Fletcher ownership change
6:01am